The Worldwide Market for Pediatric Drugs

 
   Single User - $2,625
   Hard Copy Mail Delivery - $2,625
   Corporate License - $5,250
   Online Download plus 1 Hard Copy - $2,925


Loading...
Published Oct 1, 2002 | 538 Pages | Pub ID: KLI765719

Special Offer. Now 25% off the original price of $3500.
The market for pediatric pharmaceuticals has become an increasingly important tool in life-cycle management. However, line extensions using children’s formulations to increase patent life of existing adult dose drugs are only one of the drivers of this large, but little-studied market. The increased use of pharmaceuticals in the pediatric population, the demographics of the world population, and the advent of several major children’s health initiatives have all added to the vitality of this segment.

This new study from Kalorama examines the status and future prospects (through 2006) of pediatric drug markets worldwide, including complete market size, growth, and share information for drugs in the following segments:

  • Allergy and Respiratory Drugs
  • Anti-Infectives
  • Cancer Therapies
  • Cardiovascular Drugs
  • Central Nervous System Drugs
  • Gastrointestinal Drugs
  • Hormone Drugs
  • Urological Drugs
  • Other Pediatric Pharmaceuticals

In addition, the report analyzes important regulatory, business, and clinical trends such as

  • Line extensions using children’s formulations to increase patent life
  • Recognizing unmet needs for pediatric populations
  • Labeling for pediatric indication
  • Lack of clinical trials involving children
  • Lack of development of drugs for children
  • Compliance issues
  • Generic drug manufacturer participation and impact

Extensive demographic data concerning the growth of the population under 18 by country is presented, as is the best available epidemiological statistics on major diseases and conditions. Corporate profiles for leading and significant competitors are also included.

Executive Summary

    Introduction
    Scope and Methodology
    Size and Growth of the Market
    Issues and Trends Affecting the World Prescription Pediatric Market
    Leading Competitors

Introduction

    Evolution of Child Healthcare

    History and Growth of the Pediatric Drug Market

    • Absorption
    • Distribution
    • Biotransformation
    • Excretion

    Demographics

    Treatment Guidelines for Pediatric Populations

Allergy and Respiratory Drugs

    Description of Conditions and Diseases
    • Seasonal Conditions
      • Allergic Conjunctivitis
      • Allergic Rhinitis

    • Long-Term Conditions
      • Asthma

    • Respiratory Distress Syndrome

    Prevalence and Incidence

    • Allergic Conjunctivitis
    • Allergic Rhinitis
    • Asthma
    • Respiratory Distress Syndrome (RDS)

    Description of Products

    • Antihistamines and Combinations
    • Antiasthmatic Agents
    • Bronchodilators
    • Corticosteroids
    • Decongestants and Combinations
    • Expectorants, Antitussives and Combinations
    • Lung Surfactants

    Market Overview

    • Market by Product Type
    • Market by Geographic Region

    Competitive Analysis

Anti-Infectives

    Description of Conditions and Diseases
    • Respiratory Viral and Bacterial Conditions and Diseases
      • Upper Respiratory Tract Infections
      • Lower Respiratory Tract Infections

    • Blood and Immune-Related Bacterial and Viral Infections
      • AIDS/HIV
      • Hepatitis
      • Herpes
      • Mononucleosis
      • Meningitis

    • Childhood Diseases
      • Chickenpox (Varicella)
      • Polio
      • Rubella

    • Urinary Tract Infections (UTI)
    • Parasitic Infections
      • Head Lice
      • Intestinal Parasitic Diseases

    • Miscellaneous Bacterial and Viral Infections
      • Conjunctivitis
      • Cystic Fibrosis

    • Prevalence and Incidence
      • Bronchitis
      • Chickenpox (varicella)
      • Croup
      • Cystic Fibrosis
      • Head Lice
      • Hepatitis
      • Herpes
      • HIV/AIDS
      • Influenza
      • Intestinal Parasitic Diseases
      • Measles
      • Meningitis
      • Mononucleosis
      • Otitis Media
      • Polio Virus
      • Respiratory Syncytial Virus (RSV)
      • Sinusitis
      • Strep throat/Tonsillitis
      • Urinary Tract Infection (UTI)

      Description of Products

      • Antibiotics
        • Penicillins
        • Cephlasporins
        • Monobactams
        • Carbapenems
        • Aminoglycosides
        • Sulfonamides
        • Macrolides
        • Tetracyclines
        • Miscellaneous Antibiotics

      • Anti-fungals
      • Anti-parasitics
      • Antivirals
        • Nucleoside Reverse Transcriptase Inhibitors
        • Non-nucleoside Reverse Transcriptase Inhibitors
        • Protease Inhibitors
        • Other Antivirals

      • Miscellaneous Anti-Infectives
        • Antitubercular Agents
        • Antimalarials

        Market Overview

        • Market by Product Type
        • Market by Geographic Region

        Competitive Analysis

Cancer Therapies

    Description of Diseases
    • Leukemia
    • Lymphomas
    • Brain Tumors
    • Neuroblastoma
    • Osteogenic Sarcoma
    • Ewing’s Sarcoma
    • Wilms Tumor
    • Rhabdomyosarcoma
    • Retinoblastoma

    Incidence

    Description of Products

    • Alkylating Agents
    • Antimetabolites
    • Antineoplastic Antibiotics
    • Mitotic Inhibitors
    • Miscellaneous Cancer Therapies

    Market Overview

    • Market by Product Type
    • Market by Geographic Region

    Competitive Analysis

Cardiovascular Drugs

    Description of Conditions and Diseases
    • Congenital Heart Disease (CHD)
    • Congestive Heart Failure (CHF)
    • Hypertension
    • Hyperlipidemia/Hypercholesterolemia
    • Cardiomyopathy

    Prevalence and Incidence

    • Congenital Heart Disease
    • Congestive Heart Failure
    • Hypertension
    • Hyperlipidemia/Hypercholesterolemia
    • Cardiomyopathy

    Description of Products

    • Anticoagulants
    • Antidysrhythmics
    • Antihypertensives
    • Cardiac Glycosides
    • Miscellaneous Cardiovascular Drugs

    Market Overview

    • Market by Product Type
    • Market by Geographic Region

    Competitive Analysis

Central Nervous System Drugs

    Description of Conditions and Diseases
    • Epilepsy
    • Attention Deficit Hyperactivity Disorder
    • Childhood Depression
    • Mental Disorders
    • Pain
      • Right Drug
      • Right Dose
      • Right Route
      • Right Time

    • Anesthesia
    • Enuresis
    • Juvenile Rheumatoid Arthritis

    Prevalence and Incidence

    • Attention Deficit Hyperactivity Disorder (ADHD)
    • Childhood and Adolescent Depression
    • Enuresis
    • Epilepsy
    • Juvenile Rheumatoid Arthritis
    • Other Mental Disorders

    Description of Products

    • Analgesics and Non-steroidal Anti-inflammatory Drugs
    • Anesthetics
    • Antidepressants
    • Antipsychotics
    • Antiseizure Agents
    • Central Nervous Stimulants
    • Sedatives, Hypnotics, and Anxiolytics
    • Miscellaneous Central Nervous System Drugs

    Market Overview

    • Market by Product Type
    • Market by Geographic Region

    Competitive Analysis

Gastrointestinal Drugs

    Description of Conditions and Diseases
    • Chronic Conditions
      • Gastroesophageal Reflux
      • Inflammatory Bowel Disease
      • Irritable Bowel Syndrome
      • Peptic Ulcer Disease

    • Acute Conditions
      • Nausea and Vomiting
      • Diarrhea
      • Constipation

      Prevalence and Incidence

      • Gastroesophageal Reflux (GER)
      • Inflammatory Bowel Disease
      • Peptic Ulcer Disease
      • Irritable Bowel Syndrome

      Description of Products

      • Antidiarrheals
      • Antiemetics/Emetics
      • Histamine H2 Antagonists
      • Miscellaneous Gastrointestinal Drugs

      Market Overview

      • Market by Product Type
      • Market by Geographic Region

      Competitive Analysis

Hormone Drugs

    Description of Conditions and Diseases
    • Hypopituitarism
    • Precocious Puberty
    • Diabetes Insipidus
    • Hypothyroidism
    • Hyperthyroidism
    • Lymphocytic Thyroiditis
    • Diabetes Mellitus

    Prevalence and Incidence

    • Diabetes Insipidus
    • Diabetes Mellitis
    • Hyperthyroidism
    • Hypopitutitarism
    • Hypothyroidism
    • Lymphocytic Thyroiditis
    • Precocious Puberty

    Description of Products

    • Antidiabetic Agents
    • Antidiuretic Hormones
    • Growth Hormone Drugs
    • Steroids/Corticosteroids
    • Thyroid Drugs

    Market Overview

    • Market by Product Type
    • Market by Geographic Region

    Competitive Analysis

Other Prescription Pediatric Drugs

    Description of Conditions and Diseases
    • Dental
    • Dermatological
    • Ophthalmic

    Prevalence and Incidence

    • Acne
    • Dental Caries
    • Glaucoma

    Description of Products

    • Dental Products
      • Fluoride Supplements

    • Dermatologic Drugs
    • Ophthalmic Drugs
    • Miscellaneous Drugs

    Market Overview

    • Market by Product Type
    • Market by Geographic Region

    Competitive Analysis

Research and Development

Issues and Trends

  • Addressing Unmet Medical Needs of the Pediatric Population
  • Clinical Trials for Pediatric Populations
  • Geographic Issues and Trends
  • Compliance Issues
  • Off-Label Use of Adult Drugs on Children
  • Labeling for Pediatric Indications
  • Marketing Strategies for Manufacturers
    • Patent Life Extensions

  • FDA Initiatives
    • Global Initiatives

  • Pharmaceutical Company Challenges
    • Internal Challenges
    • Solutions
    • External Challenges

  • Advertising

Market Summary

    Total market Size and Forecast
    • Markets by Segments
    • Market by Geographical Region

    Competitive Analysis

    Market Analysis

Corporate Profiles

    Leading Company Profiles
    • Abbott Laboratories
    • Aventis
    • Bayer Corporation
    • Boehringer Ingelheim GmbH
    • Bristol-Myers Squibb Company
    • Colgate Oral Pharmaceuticals, Inc.
    • Eli Lilly & Company
    • Forest Laboratories, Inc.
    • Genentech, Inc.
    • GlaxoSmithKline plc
    • Johnson & Johnson
    • MedImmune, Inc.
    • Merck & Company, Inc.
    • Novartis Pharmaceuticals Corporation
    • Novo Nordisk Pharmaceuticals, Inc.
    • Pfizer, Inc.
    • Pharmacia Corporation
    • Roche Group
    • Schering-Plough Corporation
    • Wyeth

Other and Emerging Companies at a Glance

  • Alcon Pharmaceuticals
  • Alkermes, Inc.
  • Allergan
  • Alza Corporation
  • Antex Biologics
  • Ascent Pediatrics
  • AstraZeneca plc
  • Baxter International, Inc.
  • Celltech Group plc
  • Chiron Corporation
  • Daiichi Pharmaceutical
  • Dey L.P.
  • Discovery Laboratories, Inc.
  • Elan Corporation plc
  • Genzyme Corporation
  • ICN Pharmaceuticals, Inc.
  • Targacept (Layton BioSciences)
  • Mallinckrodt Pharmaceuticals
  • Milkhaus Laboratory, Inc.
  • Muro Pharmaceutical, Inc.
  • Nastech Pharmaceutical Company, Inc.
  • Orphan Medical, Inc.
  • Pharmacyclics, Inc.
  • Sepracor, Inc.
  • Shire Pharmaceuticals Group PLC
  • Triangle Pharmaceuticals, Inc.
  • Vertex Pharmaceuticals, Inc.

Regulatory Authorities & Organizations Directory

Company Directory

List of Tables

  • Table 1-1: The World Market for Prescription Pediatric Drugs by Type, 1996-2006
  • Table 2-1: World Pediatric Population by Age and Geographic Region, 1996-2006
  • Table 2-2: World Pediatric Population by Development Level, 1998-2006
  • Table 2-3: World Population Distribution by General Age Group, 1996, 2001, 2006, 2025, 2050
  • Table 3-1: World Prevalence, Incidence, and Mortality of Selected Pediatric Allergy and Respiratory Conditions
  • Table 3-2: Selected Prescription Antihistamines and Combinations for Pediatric Administration
  • Table 3-3: Selected Prescription Antiasthmatics for Pediatric Administration
  • Table 3-4: Selected Prescription Bronchodilators for Pediatric Administration
  • Table 3-5: Selected Prescription Corticosteroids for Pediatric Administration
  • Table 3-6: Selected Prescription Decongestants and Combinations for Pediatric Administration
  • Table 3-7: Selected Prescription Expectorants for Pediatric Administration
  • Table 3-8: Selected Prescription Lung Surfactants for Pediatric Administration
  • Table 3-9: The World Market for Prescription Pediatric Drugs, Allergy and Respiratory Drugs, 1996-2006
  • Table 3-10: The World Market for Prescription Pediatric Allergy and Respiratory Drugs by Product Type, 1996-2006
  • Table 3-11: The World Market for Prescription Pediatric Allergy and Respiratory Drugs, Distribution of Share by Type, 1996-2006
  • Table 3-12: The World Market for Prescription Pediatric Drugs, Allergy and Respiratory Drugs by Geographic Region, 1996-2006
  • Table 3-13: Leading Suppliers’ Shares of the World Market for Prescription Pediatric Drugs: Allergy and Respiratory Drugs, 2001
  • Table 4-1: Global Prevalence, Incidence and Mortality of Selected Viral and Bacterial Infections
  • Table 4-2: Selected Prescription Antibiotics for Pediatric Administration
  • Table 4-3: Selected Prescription Antifungals for Pediatric Administration
  • Table 4-4: Selected Prescription Antiparasitics for Pediatric Administration
  • Table 4-5: Selected Prescription Anti-virals for Pediatric Administration
  • Table 4-6: Selected Prescription Miscellaneous Anti-infectives for Pediatric Administration
  • Table 4-7: The World Market for Prescription Pediatric Drugs, Anti-Infectives, 1996-2006
  • Table 4-8: The World Market for Prescription Pediatric Drugs, Anti-Infectives by Product Type, 1996-2006
  • Table 4-9: The World Market for Prescription Pediatric Drugs, Anti-Infectives by Percent and Product Type, 1996-2006
  • Table 4-10: The World Market for Prescription Pediatric Drugs, Anti-Infectives by Geographic Region, 1996-2006
  • Table 4-11: Leading Suppliers’ Shares of the World Market for Prescription Pediatric Anti-Infectives, 2001
  • Table 5-1: World Incidence of Selected Pediatric Cancers
  • Table 5-2: Selected Prescription Alkylating Agents for Pediatric Administration
  • Table 5-3: Selected Prescription Antimetabolites for Pediatric Administration
  • Table 5-4: Selected Prescription Antineoplastic Antibiotics for Pediatric Administration
  • Table 5-5: Selected Prescription Mitotic Inhibitors for Pediatric Administration
  • Table 5-6: Selected Prescription Miscellaneous Cancer Therapies for Pediatric Administration
  • Table 5-7: The World Market for Prescription Pediatric Cancer Therapies, 1996-2006
  • Table 5-8: The World Market for Prescription Pediatric Cancer Therapies by Product Type, 1996-2006
  • Table 5-9: The World Market for Prescription Pediatric Cancer Therapies by Percent and Product Type, 1996-2006
  • Table 5-10: The World Market for Prescription Pediatric Cancer Therapies by Geographic Region, 1996-2006
  • Table 5-11: Leading Suppliers’ Shares of the World Market for Prescription Pediatric Cancer Therapies, 2001
  • Table 6-1: World Prevalence, Incidence and Mortality of Cardiovascular Conditions in Pediatric Population
  • Table 6-2: Selected Prescription Anticoagluants for Pediatric Administration
  • Table 6-3: Selected Prescription Antidysrhythmics for Pediatric Administration
  • Table 6-4: Selected Prescription Antihypertensives for Pediatric Administration
  • Table 6-5: Selected Prescription Cardiac Glycosides for Pediatric Administration
  • Table 6-6: Selected Prescription Miscellaneous Cardiovascular Drugs for Pediatric Administration
  • Table 6-7: The World Market for Prescription Pediatric Drugs, Cardiovascular Drugs, 1996-2006
  • Table 6-8: The World Market for Prescription Pediatric Cardiovascular Drugs by Product Type, 1996-2006
  • Table 6-9: The World Market for Prescription Pediatric Cardiovascular Drugs by Percent and Product Type, 1996-2006
  • Table 6-10: The World Market for Prescription Pediatric Drugs Cardiovascular Drugs by Geographic Region, 1996-2006
  • Table 6-11: Leading Suppliers’ Shares of the World Market for Prescription Pediatric Drugs: Cardiovascular Drugs, 2001
  • Table 7-1: World Prevalence of Selected Pediatric Central Nervous System Conditions
  • Table 7-2: Selected Prescription Analgesic and Non-steroidal , Anti-inflammatory Drugs for Pediatric Administration
  • Table 7-3: Selected Prescription Anesthetics for Pediatric Administration
  • Table 7-4: Selected Prescription Antidepressants for Pediatric Administration
  • Table 7-5: Selected Prescription Antipsychotic Drugs for Pediatric Administration
  • Table 7-6: Selected Prescription Antiseizure Agents for Pediatric Administration
  • Table 7-7: Selected Prescription Central Nervous Stimulants for Pediatric Administration
  • Table 7-8: Selected Prescription Sedatives, Hypnotics, and Anxiolytics for Pediatric Administration
  • Table 7-9: Selected Prescription Miscellaneous Central Nervous System Agents for Pediatric Administration
  • Table 7-10: The World Market for Prescription Pediatric Drugs, Central Nervous System Drugs, 1996-2006
  • Table 7-11: The World Market for Prescription Pediatric Central Nervous System Drugs by Product Type, 1996-2006
  • Table 7-12: The World Market for Prescription Pediatric Central Nervous System Drugs by Percent and Product Type, 1996-2006
  • Table 7-13: The World Market for Prescription Pediatric Drugs, Central Nervous System Drugs by Geographic Region, 1996-2006
  • Table 7-14: Leading Suppliers’ Shares of the World Market for Prescription Pediatric Central Nervous System Drugs, 2001
  • Table 8-1: Global Prevalence, Incidence, and Mortality of Gastrointestinal Conditions in Pediatric Populations
  • Table 8-2: Selected Prescription Antidiarrheals for Pediatric Administration:
  • Table 8-3: Selected Prescription Antiemetics/Emetics Drugs for Pediatric Administration
  • Table 8-4: Selected Prescription Histamine H2 Antagonists for Pediatric Administration
  • Table 8-5: Selected Prescription Miscellaneous Gastrointestinal Drugs for Pediatric Administration
  • Table 8-6: The World Market for Prescription Pediatric Drugs, Gastrointestinal Drugs, 1996-2006
  • Table 8-7: The World Market for Prescription Pediatric Gastrointestinal Drugs by Product Type, 1996-2006
  • Table 8-8: The World Market for Prescription Pediatric Gastrointestinal Drugs by Percent and Product Type, 1996-2006
  • Table 8-9: The World Market for Prescription Pediatric Drugs: Gastrointestinal Drugs by Geographic Region, 1996-2006
  • Table 8-10: Leading Suppliers’ Shares of the World Market for Prescription Pediatric Gastrointestinal Drugs, 2001
  • Table 9-1: World Incidence and Prevalence of Selected Pediatric Hormone Conditions
  • Table 9-2: Selected Prescription Antidiabetic Agents for Pediatric Administration
  • Table 9-3: Selected Prescription Antidiuretic Hormones for Pediatric Administration
  • Table 9-4: Selected Prescription Growth Hormone Drugs for Pediatric Administration
  • Table 9-5: Selected Prescription Steroids/Corticosteroids for Pediatric Administration
  • Table 9-6: Selected Prescription Thyroid Drugs for Pediatric Administration
  • Table 9-7: The World Market for Prescription Pediatric Drugs, Hormone Drugs, 1996-2006
  • Table 9-8: The World Market for Prescription Pediatric Hormone Drugs by Product Type, 1996-2006
  • Table 9-9: The World Market for Prescription Pediatric Hormone Drugs by Percent and Product Type, 1996-2006
  • Table 9-10: The World Market for Prescription Pediatric Drugs: Hormone Drugs by Geographic Region, 1996-2006
  • Table 9-11: Leading Suppliers’ Shares of the World Market for Prescription Pediatric Drugs: Hormone Drugs, 2001
  • Table 10-1: World Incidence of Other Selected Pediatric Conditions
  • Table 10-2: Selected Prescription Dental Products for Pediatric Administration
  • Table 10-3: Selected Prescription Dermatologic Drugs for Pediatric Administration
  • Table 10-4: Selected Prescription Ophthalmic Drugs for Pediatric Administration
  • Table 10-5: Selected Prescription Miscellaneous Drugs for Pediatric Administration
  • Table 10-6: The World Market for Other Prescription Pediatric Drugs, 1996-2006
  • Table 10-7: The World Market for Other Prescription Pediatric Drugs by Product Type, 1996-2006
  • Table 10-8: The World Market for Other Prescription Pediatric Drugs by Percent and Product Type, 1996-2006
  • Table 10-9: The World Market for Prescription Pediatric Drugs: Other Drugs by Geographic Region, 1996-2006
  • Table 10-10: Leading Suppliers’ Shares of the World Market for Prescription Pediatric Drugs: Other Drugs, 2001
  • Table 11-1: Products Recently Approved or in Various Stages of Development for Pediatrics
  • Table 11-2: Approved Prescription Drugs for Which Additional Pediatric Information May Produce Health Benefits in the Pediatric Population as of May 2001
  • Table 11-3: Approved Prescription Biologics for Which Additional Pediatric Information May Produce Health Benefits in the Pediatric Population as of May 2001
  • Table 12-1: Pediatric Exclusivity Labeling Changes, (as of February 15, 2002)
  • Table 12-2: FDA Approved Drugs with Pediatric Exclusivity and Patent Expiration Date
  • Table 12-3: Pediatric Exclusivity Statistics as of May 1, 2002
  • Table 13-1: The World Market for Prescription Pediatric Drugs, 1996-2006
  • Table 13-2: The World Market for Prescription Pediatric Drugs by Type, 1996-2006
  • Table 13-3: The World Market for Prescription Pediatric Drugs by Type and Percent Distribution, 1996-2006
  • Table 13-4: The World Market for Prescription Pediatric Drugs by Geographical Region, 1996-2006
  • Table 13-5: The World Market for Prescription Pediatric Drugs, Revenues and Distribution by Geographic Region, 1996-2006
  • Table 13-6: Leading Suppliers Segments of Participation within the World Market for Prescription Pediatric Drugs, 2001

List of Figures

  • Figure 1-1: The World Market for Prescription Pediatric Drugs by Type and Revenues, 1996-2006
  • Figure 1-2: The World Market for Prescription Pediatric Drugs by Type and Percent Distribution, 1996-2006
  • Figure 1-3: The World Market for Prescription Pediatric Drugs by Percent and Segment, 2001
  • Figure 2-1: World Pediatric Population by Geographic Region, 1996-2006
  • Figure 2-2: World Pediatric Population by Development Level, 1998-2006
  • Figure 3-1: World Prevalence of Selected Pediatric Respiratory Conditions in Comparison to Pediatric Population
  • Figure 3-2: The World Market for Prescription Pediatric Drugs, Allergy and Respiratory Drugs, 1996-2006
  • Figure 3-3: The World Market for Prescription Pediatric Drugs: Allergy and Respiratory Drugs by Product Type and Revenues, 1996-2006
  • Figure 3-4: The World Market for Prescription Pediatric Drugs: Allergy and Respiratory Drugs by Product Type and Percent Distribution, 1996-2006
  • Figure 3-5: The World Market for Prescription Pediatric Drugs: Allergy and Respiratory Drugs by Percent and Product Type, 2001
  • Figure 3-6: The World Market for Prescription Pediatric Drugs: Allergy and Respiratory Drugs by Geographic Region, 1996-2006
  • Figure 3-7: Leading Suppliers’ Shares of the World Market for Prescription Pediatric Drugs: Allergy and Respiratory Drugs, 2001
  • Figure 4-1: World Incidence of Selected Pediatric Viral and Bacterial Infections in Comparison to Pediatric Population
  • Figure 4-2: World Prevalence of Selected Pediatric Viral Infections in Comparison to Pediatric Population
  • Figure 4-3: The World Market for Prescription Pediatric Drugs, Anti-Infectives, 1996-2006
  • Figure 4-4: The World Market for Prescription Pediatric Drugs: Anti-Infectives by Product Type and Revenues, 1996-2006
  • Figure 4-5: The World Market for Prescription Pediatric Drugs: Anti-Infectives by Product Type and Percent Distribution, 1996-20
  • Figure 4-6: The World Market for Prescription Pediatric Drugs: Anti-Infectives by Percent and Product Type, 2001
  • Figure 4-7: The World Market for Prescription Pediatric Drugs, Anti-Infectives by Geographic Region, 1996-2006
  • Figure 4-8: Leading Suppliers’ Shares of the World Market for Prescription Pediatric Anti-Infectives, 2001
  • Figure 5-1: World Incidence of Selected Pediatric Cancers as a Comparison to all Pediatric Cancers
  • Figure 5-2: The World Market for Prescription Pediatric Cancer Drugs, 1996-2006
  • Figure 5-3: The World Market for Prescription Pediatric Drugs: Cancer Therapies by Product Type and Revenues, 1996-2006
  • Figure 5-4: The World Market for Prescription Pediatric Drugs: Cancer Therapies by Product Type and Percent Distribution, 1996-2006
  • Figure 5-5: The World Market for Prescription Pediatric Drugs: Cancer Therapies by Percent and Product Type, 2001
  • Figure 5-6: The World Market for Prescription Pediatric Drugs: Cancer Therapies by Geographic Region, 1996-2006
  • Figure 5-7: Leading Suppliers’ Shares of the World Market for Prescription Pediatric Cancer Therapies, 2001
  • Figure 6-1: World Prevalence of Pediatric Cardiovascular Conditions in Comparison to Pediatric Populations
  • Figure 6-2: The World Market for Prescription Pediatric Drugs: Cardiovascular Drugs, 1996-2006
  • Figure 6-3: The World Market for Prescription Pediatric Drugs: Cardiovascular Drugs by Product Type and Revenues, 1996-2006
  • Figure 6-4: The World Market for Prescription Pediatric Drugs: Cardiovascular Drugs by Product Type and Percent Distribution, 1996-2006
  • Figure 6-5: The World Market for Prescription Pediatric Drugs: Cardiovascular Drugs by Percent and Product Type, 2001
  • Figure 6-6: The World Market for Prescription Pediatric Drugs: Cardiovascular Drugs by Geographic Region, 1996-2006
  • Figure 6-7: Leading Suppliers’ Shares of the World Market for Prescription Pediatric Drugs: Cardiovascular Drugs, 2001
  • Figure 7-1: World Prevalence of Selected Pediatric Central Nervous System Conditions in Comparison to Pediatric Population
  • Figure 7-2: The World Market for Prescription Pediatric Drugs, Central Nervous System Drugs, 1996-2006
  • Figure 7-3: The World Market for Prescription Pediatric Drugs: Central Nervous System Drugs by Product Type and Revenues, 1996-2006
  • Figure 7-4: The World Market for Prescription Pediatric Drugs: Central Nervous System Drugs by Product Type and Percent Distribution, 1996-2006
  • Figure 7-5: The World Market for Prescription Pediatric Drugs: Central Nervous System Drugs by Percent and Product Type, 2001
  • Figure 7-6: The World Market for Prescription Pediatric Drugs: Central Nervous System Drugs by Geographic Region, 1996-2006
  • Figure 7-7: Leading Suppliers’ Shares of the World Market for Prescription Pediatric Drugs: Central Nervous System Drugs, 2001
  • Figure 8-1: World Incidence of Pediatric Gastrointestinal Conditions in Comparison to Pediatric Population
  • Figure 8-2: World Prevalence of Pediatric Gastrointestinal Conditions Compared to Pediatric Populations
  • Figure 8-3: The World Market for Prescription Pediatric Drugs: Gastrointestinal Drugs, 1996-2006
  • Figure 8-4: The World Market for Prescription Pediatric Drugs: Gastrointestinal Drugs by Product Type and Revenues, 1996-2006
  • Figure 8-5: The World Market for Prescription Pediatric Drugs: Gastrointestinal Drugs by Product Type and Percent Distribution, 1996-2006
  • Figure 8-6: The World Market for Prescription Pediatric Drugs: Gastrointestinal Drugs by Percent and Product Type, 2001
  • Figure 8-7: The World Market for Prescription Pediatric Drugs: Gastrointestinal Drugs by Geographic Region, 1996-2006
  • Figure 8-8: Leading Suppliers’ Shares of the World Market for Prescription Pediatric Drugs: Gastrointestinal Drugs, 2001
  • Figure 9-1: World Incidence of Selected Pediatric Hormone Conditions in Comparison to Pediatric Population
  • Figure 9-2: World Prevalence of Selected Pediatric Hormone Conditions in Comparison to Pediatric Population
  • Figure 9-3: The World Market for Prescription Pediatric Drugs, Hormone Drugs, 1996-2006
  • Figure 9-4: The World Market for Prescription Pediatric Drugs: Hormone Drugs by Product Type and Revenues, 1996-2006
  • Figure 9-5: The World Market for Prescription Pediatric Drugs: Hormone Drugs by Product Type and Percent Distribution, 1996-2006
  • Figure 9-6: The World Market for Prescription Pediatric Drugs: Hormone Drugs by Percent and Product Type, 2001
  • Figure 9-7: The World Market for Prescription Pediatric Drugs: Hormone Drugs by Geographic Region, 1996-2006
  • Figure 9-8: Leading Suppliers’ Shares of the World Market for Prescription Pediatric Drugs: Hormone Drugs, 2001
  • Figure 10-1: World Incidence/Prevalence of Other Pediatric Conditions in Comparison to Pediatric Populations
  • Figure 10-2: The World Market for Other Prescription Pediatric Drugs, 1996-2006
  • Figure 10-3: The World Market for Prescription Pediatric Drugs: Other Drugs by Product Type and Revenues, 1996-2006
  • Figure 10-4: The World Market for Prescription Pediatric Drugs: Other Drugs by Product Type and Percent Distribution, 1996-2006
  • Figure 10-5: The World Market for Prescription Pediatric Drugs: Other Drugs by Percent and Product Type, 2001
  • Figure 10-6: The World Market for Prescription Pediatric Drugs: Other Drugs by Geographic Region, 1996-2006
  • Figure 10-7: Leading Suppliers’ Shares of the World Market for Prescription Pediatric Drugs: Other Drugs, 2001
  • Figure 13-1: The World Market for Prescription Pediatric Drugs, 1996-2006
  • Figure 13-2: The World Market for Prescription Pediatric Drugs by Type and Revenues, 1996-2006
  • Figure 13-3: The World Market for Prescription Pediatric Drugs by Type and Percent Distribution, 1996-2006
  • Figure 13-4: The World Market for Prescription Pediatric Drugs by Percent and Segment, 2001
  • Figure 13-5: The World Market for Prescription Pediatric Drugs, Revenues by Geographic Region, 1996-2006
  • Figure 13-6: The World Market for Prescription Pediatric Drugs by Geographical Region and Percent Distribution, 1996-2006

In this report, {{keyword[keywordTextProperty]}} appears {{keyword[keywordCountProperty]}} times. {{searchResults.STATRESULT.SUMMARY.KW[keywordTextProperty]}} appears {{searchResults.STATRESULT.SUMMARY.KW[keywordCountProperty]}} times.

We were unable to search inside this report.
No results matched your search criteria.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.